Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Zollinger-Ellison Syndrome × Esomeprazole × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Zollinger-Ellison Syndrome 1 Vomiting 1 Precancerous Conditions 1 Nausea 1 Esophageal Neoplasms 1 Breast Neoplasms 1 Barrett Esophagus 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00079833 2010-11-19

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

AstraZeneca

Phase 3 Completed

Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡